Weight loss in women taking flibanserin for hypoactive sexual desire disorder (HSDD): Insights into potential mechanisms

Articles

Weight loss in women taking flibanserin for hypoactive sexual desire disorder (HSDD): Insights into potential mechanismsIntroduction: Flibanserin, a multifunctional serotonin receptor agonist and antagonist, is currently approved in the United States and Canada for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. A post hoc analysis of HSDD clinical trial…